Search results
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition
The Hill· 2 hours agoThe Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and< ...
Is Eli Lilly Stock A Buy After Weight-Loss Drug Crushes Quarterly Sales Forecasts?
Investor's Business Daily· 4 hours agoSales of Mounjaro and another diabetes treatment, Trulicity, lagged forecasts. ...Lilly says it's...
FTC Targets ‘Junk’ Patent Listings on Ozempic and Other Drugs
The Wall Street Journal· 4 hours agoAt issue is what is called the Orange Book, a document published by the Food and Drug Administration...
Lilly Soars as Forecast Boost Shows Weight-Loss Drugs’ Power
Bloomberg via Yahoo Finance· 2 hours ago(Bloomberg) -- Eli Lilly & Co.’s shares soared as its brighter outlook for 2024 raised the potential...
Drug appears to reverse type 1 diabetes in mice
Futurity· 4 hours agoAn experimental monoclonal antibody drug appears to prevent and reverse the onset of clinical type 1 diabetes in mice, and< ...
Some of the popular weight loss drug Wegovy is back on shelves after a shortage, the FDA says
Quartz· 23 hours agoA dose of Wegovy’s highly-coveted weight loss drug is no longer in limited supply, according to Food...
Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion
Reuters· 2 hours ago, opens new tab weight-loss drug Zepbound drove the company to raise its annual sales forecast by $2...
This Popular Weight Loss Drug May Help People With Sleep Apnea, Study Finds
Prevention· 4 days agoZepbound, a popular weight loss drug from Eli Lilly, may help people with sleep apnea. Based on...
Why Eli Lilly's earnings are no sure thing for traders despite obesity drug momentum
CNBC· 1 day agoEli Lilly appears to be making as much of its popular obesity and diabetes medicines as it can, but...
Lilly hikes revenue forecast by $2B as GLP-1 drug sales climb
BioPharma Dive via Yahoo Finance· 9 hours agoCertain doses of both Mounjaro and Zepbound are currently in shortage on a database maintained by...